DE69942767D1 - Gbs toxin rezeptor - Google Patents
Gbs toxin rezeptorInfo
- Publication number
- DE69942767D1 DE69942767D1 DE69942767T DE69942767T DE69942767D1 DE 69942767 D1 DE69942767 D1 DE 69942767D1 DE 69942767 T DE69942767 T DE 69942767T DE 69942767 T DE69942767 T DE 69942767T DE 69942767 D1 DE69942767 D1 DE 69942767D1
- Authority
- DE
- Germany
- Prior art keywords
- toxin receptor
- gbs toxin
- polypeptides
- polynucleotides
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9384398P | 1998-07-22 | 1998-07-22 | |
PCT/US1999/016676 WO2000005375A1 (en) | 1998-07-22 | 1999-07-22 | Gbs toxin receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69942767D1 true DE69942767D1 (de) | 2010-10-28 |
Family
ID=22241140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69942767T Expired - Lifetime DE69942767D1 (de) | 1998-07-22 | 1999-07-22 | Gbs toxin rezeptor |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1098978B1 (de) |
JP (2) | JP4598272B2 (de) |
CN (1) | CN100480387C (de) |
AT (1) | ATE481486T1 (de) |
AU (1) | AU5125799A (de) |
CA (1) | CA2333466C (de) |
DE (1) | DE69942767D1 (de) |
HK (1) | HK1040263A1 (de) |
WO (1) | WO2000005375A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1098978B1 (de) * | 1998-07-22 | 2010-09-15 | Vanderbilt University | Gbs toxin rezeptor |
US8609614B2 (en) | 1998-07-22 | 2013-12-17 | Vanderbilt University | GBS toxin receptor compositions and methods of use |
GB9915200D0 (en) | 1999-06-29 | 1999-09-01 | Janssen Pharmaceutica Nv | Neurotrophic factor receptor |
MXPA01009917A (es) | 2000-02-02 | 2003-08-01 | Univ Vanderbilt | Metodos para prevenir o atenuar condiciones angiogenicas patologicas. |
JP5317056B2 (ja) * | 2007-05-18 | 2013-10-16 | 国立大学法人 岡山大学 | アスパラギン酸の化学伝達を司るトランスポーターの同定とその利用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811403A (en) * | 1996-09-30 | 1998-09-22 | Vanderbilt University | Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity |
EP1098978B1 (de) * | 1998-07-22 | 2010-09-15 | Vanderbilt University | Gbs toxin rezeptor |
-
1999
- 1999-07-22 EP EP99935873A patent/EP1098978B1/de not_active Expired - Lifetime
- 1999-07-22 JP JP2000561321A patent/JP4598272B2/ja not_active Expired - Fee Related
- 1999-07-22 CA CA2333466A patent/CA2333466C/en not_active Expired - Fee Related
- 1999-07-22 DE DE69942767T patent/DE69942767D1/de not_active Expired - Lifetime
- 1999-07-22 AU AU51257/99A patent/AU5125799A/en not_active Abandoned
- 1999-07-22 WO PCT/US1999/016676 patent/WO2000005375A1/en active Application Filing
- 1999-07-22 CN CNB998107069A patent/CN100480387C/zh not_active Expired - Fee Related
- 1999-07-22 AT AT99935873T patent/ATE481486T1/de not_active IP Right Cessation
-
2002
- 2002-03-01 HK HK02101588.4A patent/HK1040263A1/zh unknown
-
2009
- 2009-11-12 JP JP2009259008A patent/JP5475406B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100480387C (zh) | 2009-04-22 |
JP4598272B2 (ja) | 2010-12-15 |
JP2010099072A (ja) | 2010-05-06 |
EP1098978B1 (de) | 2010-09-15 |
CA2333466A1 (en) | 2000-02-03 |
WO2000005375A9 (en) | 2000-11-16 |
WO2000005375A1 (en) | 2000-02-03 |
AU5125799A (en) | 2000-02-14 |
CN1317047A (zh) | 2001-10-10 |
HK1040263A1 (zh) | 2002-05-31 |
JP5475406B2 (ja) | 2014-04-16 |
CA2333466C (en) | 2012-05-01 |
ATE481486T1 (de) | 2010-10-15 |
JP2002524027A (ja) | 2002-08-06 |
EP1098978A1 (de) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200000320A (et) | Uudsed ühendid | |
SE9704544D0 (sv) | Novel compounds | |
SE9704546D0 (sv) | Novel compounds | |
NO20001409D0 (no) | Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger | |
GR1003350B (el) | Νεες ενωσεις | |
DK0966454T3 (da) | Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler | |
PT911340E (pt) | Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos | |
IS1903B (is) | 2-methýl-thíenó-bensódíasepín, samsetning til inntöku | |
HU9603495D0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents | |
TR200200785T2 (tr) | 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri | |
NO992102L (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
DE69300913T2 (de) | Polymorph Terazosin und pharmazeutische Zusammenstellung. | |
DZ2283A1 (fr) | Composition de vaccin. | |
TR200103108T2 (tr) | Bradikinin reseptör antagonistleri | |
TR199900089A3 (tr) | Trovafloksasin mesilat tablet. | |
DE60016363D1 (de) | Aminoalkohol-Derivat und Medikament, das dieses Derivat enthält | |
NO983472D0 (no) | Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene | |
ATE481486T1 (de) | Gbs toxin rezeptor | |
NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
BRPI9703099B8 (pt) | derivado de carboidrato, e, composição farmacêutica | |
TR199800152T1 (xx) | Endotelin Resept�r Antagonistleri | |
NO20013878L (no) | (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme | |
ZA981275B (en) | Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions. | |
AU2001295836A1 (en) | Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis | |
FI972988A0 (fi) | Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä |